ARCA biopharma Inc (ABIO)
3.28
+0.11
(+3.47%)
USD |
NASDAQ |
Apr 18, 16:00
3.28
0.00 (0.00%)
After-Hours: 20:00
ARCA biopharma Enterprise Value: 8.538M for April 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 17, 2024 | 8.538M |
| April 16, 2024 | 9.988M |
| April 15, 2024 | 8.682M |
| April 12, 2024 | 9.408M |
| April 11, 2024 | 9.698M |
| April 10, 2024 | 8.102M |
| April 09, 2024 | 7.957M |
| April 08, 2024 | 6.072M |
| April 05, 2024 | 7.377M |
| April 04, 2024 | 7.232M |
| April 03, 2024 | 9.698M |
| April 02, 2024 | -12.63M |
| April 01, 2024 | -12.05M |
| March 28, 2024 | -11.91M |
| March 27, 2024 | -12.05M |
| March 26, 2024 | -12.63M |
| March 25, 2024 | -12.34M |
| March 22, 2024 | -11.76M |
| March 21, 2024 | -11.62M |
| March 20, 2024 | -12.05M |
| March 19, 2024 | -12.20M |
| March 18, 2024 | -12.49M |
| March 15, 2024 | -12.92M |
| March 14, 2024 | -12.78M |
| March 13, 2024 | -12.92M |
| Date | Value |
|---|---|
| March 12, 2024 | -13.36M |
| March 11, 2024 | -13.58M |
| March 08, 2024 | -13.65M |
| March 07, 2024 | -13.79M |
| March 06, 2024 | -13.36M |
| March 05, 2024 | -13.21M |
| March 04, 2024 | -13.07M |
| March 01, 2024 | -13.21M |
| February 29, 2024 | -13.50M |
| February 28, 2024 | -13.21M |
| February 27, 2024 | -12.92M |
| February 26, 2024 | -13.50M |
| February 23, 2024 | -13.79M |
| February 22, 2024 | -13.79M |
| February 21, 2024 | -13.84M |
| February 20, 2024 | -13.65M |
| February 16, 2024 | -13.21M |
| February 15, 2024 | -13.50M |
| February 14, 2024 | -13.65M |
| February 13, 2024 | -14.23M |
| February 12, 2024 | -13.36M |
| February 09, 2024 | -13.36M |
| February 08, 2024 | -13.50M |
| February 07, 2024 | -14.23M |
| February 06, 2024 | -14.37M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-27.85M
Minimum
Jan 28 2022
30.30M
Maximum
Jul 31 2020
-8.527M
Average
-11.17M
Median
May 08 2023
Enterprise Value Benchmarks
| Shockwave Medical Inc | 11.99B |
| Asensus Surgical Inc | 49.65M |
| Glaukos Corp | 4.850B |
| Helius Medical Technologies Inc | -0.5858M |
| Perspective Therapeutics Inc | 831.78M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.089M |
| Total Expenses (Quarterly) | 1.59M |
| EPS Diluted (Quarterly) | -0.08 |
| Earnings Yield | -11.28% |